Business Context and Reporting Period
This Form 8-K filing by Progyny, Inc. (PGNY) reports a corporate governance event dated January 10, 2025. The filing details the appointment of a new director to the Board of Directors and outlines the associated compensatory arrangements.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on director compensation and appointment details.
Material Changes
The primary material change is the appointment of Debra Morris as a Class III director, effective January 16, 2025. She has also been appointed to the Compensation Committee. Her term will expire at the 2025 annual meeting of stockholders.
Guidance, Outlook, and Management Commentary
There is no forward-looking guidance, outlook, or management commentary regarding business operations or financial projections in this filing. The document details the following compensation structure for Ms. Morris:
- Cash Retainer: $40,000 annually, payable quarterly in arrears and prorated for partial quarters.
- Initial Equity Grant: Options to purchase 44,000 shares of common stock granted on January 16, 2025. Vesting schedule: 25% on the first anniversary, with the remainder vesting in equal quarterly installments over the subsequent three years.
- Annual Equity Grants: Eligibility for annual grants of options valued at $338,587 and restricted stock units (RSUs) valued at $139,750, granted at each annual meeting and vesting on the first anniversary.
No risks, contingencies, or unusual items are disclosed in this specific report.
Investor Verification Checklist
- Verify the effective date of Debra Morris's directorship (January 16, 2025) and her committee assignments.
- Confirm the total value of the initial equity grant (44,000 options) and the specific vesting schedule.
- Review the Company's 2019 Equity Incentive Plan to understand the terms of the option grants.
- Check for any subsequent filings regarding the 2025 annual meeting of stockholders where her term will expire.